NCT01529684View on ClinicalTrials.gov

A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 19, 2012

Primary Completion Date

December 8, 2012

Study Completion Date

February 20, 2013

Conditions
Advanced Solid TumorsPharmacokinetics of 14C-OSI-906
Interventions
DRUG

radio-labeled OSI-906

Part A: oral solution of 14C-OSI-906

DRUG

OSI-906

Part B: oral tablets OSI-906

Trial Locations (2)

98405

Northwest Medical Specialties, PLLC, Tacoma

98418

Comprehensive Clinical Development NW, Inc., Tacoma

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT01529684 - A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body | Biotech Hunter | Biotech Hunter